These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5922147)

  • 1. Psilocin: effects on behaviour and brain serotonin in mice.
    Collins RL; Ordy JM; Samorajski T
    Nature; 1966 Feb; 209(5025):785-7. PubMed ID: 5922147
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of reserpine, para-chlorophenylalanine, 5,6-dihydroxytryptamine and fludiazepam on the head twitches induced by 5-hydroxytryptamine or 5-methoxytryptamine in mice.
    Nakamura M; Fukushima H
    J Pharm Pharmacol; 1978 Apr; 30(4):254-6. PubMed ID: 24719
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-activity-relationships of certain hallucinogenic substances based on brain levels.
    Vogel WH; Evans BD
    Life Sci; 1977 May; 20(10):1629-35. PubMed ID: 69244
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical and behavioural alterations following 5,6-dihydroxytryptamine administration into brain.
    Breese GR; Cooper BR; Grant LD; Smith RD
    Neuropharmacology; 1974 Mar; 13(3):177-87. PubMed ID: 4407423
    [No Abstract]   [Full Text] [Related]  

  • 5. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular pharmacology of hallucinogens.
    Johnston VS; Bradley RJ
    Recent Adv Biol Psychiatry; 1968; 10():74-99. PubMed ID: 4872761
    [No Abstract]   [Full Text] [Related]  

  • 7. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural models of psychosis.
    Smythies JR; Johnston VS; Bradley RJ
    Br J Psychiatry; 1969 Jan; 115(518):55-68. PubMed ID: 5781961
    [No Abstract]   [Full Text] [Related]  

  • 9. Accumulation of tritiated 5-hydroxytryptamine in brain slices.
    Ross SB; Renyl AL
    Life Sci; 1967 Jul; 6(13):1407-15. PubMed ID: 4382451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmaco-biological study of hematoporphyrin].
    De Maio D; Belloni F
    Clin Ter; 1968 Dec; 47(6):591-600. PubMed ID: 5750960
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of stimulants and hallucinogens on shuttle avoidance in rats.
    Davis WM; Hatoum HT
    Gen Pharmacol; 1987; 18(2):123-8. PubMed ID: 3569841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of N,N-dimethyltryptamine in rats and mice.
    Moussatché H; Carlini EA; dos Santos M
    Rev Bras Biol; 1970 Dec; 30(4):483-9. PubMed ID: 5535408
    [No Abstract]   [Full Text] [Related]  

  • 13. Opposed behavioral syndromes in rats with partial and more complete central serotonergic lesions made with 5,6 dihydroxytryptamine.
    Diaz J; Ellison G; Masuoka D
    Psychopharmacologia; 1974 Jun; 37(1):67-79. PubMed ID: 4414929
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationships among hallucinogenic tryptamine derivatives evaluated by schedule-controlled behaviour.
    Harris RA; Homfeld E; Campaigne E
    J Pharm Pharmacol; 1981 May; 33(5):320-2. PubMed ID: 6116783
    [No Abstract]   [Full Text] [Related]  

  • 15. Amphetamine-like effects of 5,6-dihydroxy tryptamine on social behaviour in the mouse.
    Pöschlová N; Masek K; Krsiak M
    Neuropharmacology; 1977 May; 16(5):317-21. PubMed ID: 865659
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of anticholinergic hallucinogens on spontaneous and conditioned behaviour in rats.
    Kabes J; Fink Z
    Act Nerv Super (Praha); 1971; 13(3):195-6. PubMed ID: 5113839
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioural effects of some 4-substituted amphetamines.
    Beaton JM; Smythies JR; Benington F; Morin RD; Clark LC
    Nature; 1968 Nov; 220(5169):800-1. PubMed ID: 5698757
    [No Abstract]   [Full Text] [Related]  

  • 18. The comparative behavioral effects of N,N-dimethyltryptamine and N,N-diethyltryptamine in primate dyads.
    Heinze WJ; Schlemmer RF; Tyler CB; Davis JM
    Biol Psychiatry; 1983 Jul; 18(7):829-36. PubMed ID: 6577915
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-activity relationships among 5-methoxy-n:n-dimethyltryptamine, 4-hydroxy-n:n-dimethyltryptamine (psilocin) and other substituted tryptamines.
    Gessner PK; Godse DD; Krull AH; McMullan JM
    Life Sci; 1968 Mar; 7(5):267-77. PubMed ID: 5641719
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of [3H]5-HT binding to rat brain membranes by psychotomimetic amphetamines.
    De Jong AP; Huggins F; Fournier D; Makriyannis A
    Eur J Pharmacol; 1982 Sep; 83(3-4):305-8. PubMed ID: 7173311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.